Description

Brello Health GLP-1 Program Overview 2026: Pricing, Process, Compounded Semaglutide vs Tirzepatide Considerations

Brello Health is a telehealth platform, a network of independently licensed prescribers, and a partner compounding pharmacy working together to deliver compounded weight-management and longevity medications to members across the United States. As with any telehealth program built this way, understanding where each of those three pieces begins and ends matters more than the marketing copy on the homepage.

Brello positions itself specifically toward women, describing its mission as helping women “transform their lives through clinician prescribed longevity medicine.” The platform builds the intake experience, the mobile app, and the community features. Independent, licensed healthcare providers conduct the actual medical review and write any prescriptions. A separate, USA-based 503A partner pharmacy compounds and ships the approved medication. Brello does not manufacture or formulate any medication itself.

That distinction is especially important here because Brello’s core products, including compounded semaglutide and compounded tirzepatide, are not FDA-approved finished drug products. They are patient-specific preparations made by a licensed compounding pharmacy under a valid prescription. Brello states this directly on its own site: compounded drug products are not FDA-approved, and the FDA does not evaluate their safety, effectiveness, or quality. That single sentence, repeated across multiple pages on Brello’s own site, is worth keeping in mind through everything else in this overview.

Understanding the Medications Behind the Brand

Semaglutide and tirzepatide belong to a class of medications known as GLP-1 receptor agonists, originally developed for type 2 diabetes management before their weight-loss effects drove much of the current telehealth boom around them. They work by mimicking a gut hormone that slows digestion, increases satiety, and helps regulate blood sugar. Tirzepatide goes a step further, acting on both the GLP-1 receptor and the GIP receptor, a dual mechanism associated with more pronounced outcomes in the clinical trials conducted on the FDA-approved brand-name versions of the drug.

It’s worth being precise about what that clinical research actually covers. The large-scale trials demonstrating GLP-1 and GIP effectiveness were conducted using FDA-approved, commercially manufactured products, not compounded versions. Compounded semaglutide and tirzepatide use the same active pharmaceutical ingredients, but the compounded preparation itself has not gone through the FDA’s own drug approval process. Brello’s own disclaimer language reflects this directly, and it is the single most important fact for anyone comparing compounded providers to brand-name options like Ozempic, Wegovy, Mounjaro, or Zepbound.

What Brello Health Actually Offers

Brello’s core lineup includes four standalone compounded medications, plus several bundled protocols that combine them:

• Tirzepatide — starting at $166 per month, billed as a 3-month plan.
• Semaglutide — starting at $133 per month, billed as a 3-month plan.
• NAD+ — starting at $79 per month, marketed for cellular energy and longevity support.
• Sermorelin — starting at $116 per month, a growth-hormone-releasing peptide typically associated with longevity and recovery protocols.

Brello also offers three bundled “Longevity Protocols” that combine these medications into a single coordinated plan:

• Empowered+ (GLP-1 + NAD+) — starting at $199 per month.
• Thrive Forward (GLP-1 + NAD+ + Sermorelin) — starting at $299 per month, described as the most complete stack.
• Metabolic Compass (GLP-1 + Lumen Metabolism Tracker device) — starting at $166 per month, pairing medication with a metabolism-tracking hardware device and daily nutrition planning.

Every medication and bundle on this list is explicitly marked “if approved” throughout Brello’s own marketing pages, a detail worth noting because it makes clear that enrollment in a plan is not the same as automatic access to medication. Each component still requires an independent clinical determination from a licensed provider.

How the Brello Process Works

Brello describes a straightforward three-step path from sign-up to delivery:

1. Select a wellness plan and complete an online medical intake form.
2. A licensed healthcare provider reviews the submitted information to determine medical appropriateness and whether a prescription is warranted.
3. If approved, the medication ships directly to the member’s door through Brello’s partner pharmacy, along with any needed supplies such as syringes, needles, and injection instructions.

No in-person visit is required. The entire clinical review happens through the intake form and, where needed, follow-up communication with the assigned provider. Members can track their plan, message their provider, and monitor progress through the Brello mobile app, available on both iOS and Android.

One operational detail worth flagging directly to readers: at the time of this writing, Brello’s own site displays an active notice that its partner pharmacy is transitioning to a larger facility, and that temporary shipping delays should be expected during that transition, with estimated shipping times of five to seven business days for orders in states marked as available on its live coverage map. This is the kind of real-time operational detail that can change quickly, so anyone evaluating Brello for enrollment should check the current live map on Brello’s own homepage rather than relying on historical shipping estimates.

How Brello Fits Into the Broader Compounded GLP-1 Market

Brello competes in a rapidly expanding category of direct-pay, compounded GLP-1 telehealth providers, most of which follow a similar core structure: an online intake form, a licensed prescriber network, and a partner compounding pharmacy handling fulfillment. Two forces have driven this category’s growth over the past several years, persistent supply shortages of brand-name semaglutide and tirzepatide, and the significant price gap between compounded and brand-name options for patients paying entirely out of pocket.

What tends to separate one provider from another in this space comes down to a handful of concrete, checkable details rather than marketing language alone: whether pricing is billed monthly with no minimum term or bundled into a longer commitment like Brello’s 3-month structure, how narrow or generous the cancellation and refund windows are, whether community or lifestyle features are bundled into the price or sold separately, and how the company communicates about pharmacy or shipping disruptions when they happen. Brello’s decision to publish an active, real-time notice about its pharmacy transition, rather than staying silent about a shipping slowdown, is the kind of operational transparency worth noting when comparing providers, even though the resulting delay itself is an inconvenience for members mid-transition.

Brello’s differentiation strategy leans heavily into positioning: a women-focused brand voice, a private community, and bundled fitness and nutrition content, rather than competing purely on the lowest possible sticker price. Members comparing Brello against other compounded GLP-1 or longevity telehealth providers should weigh whether those community and lifestyle features carry real value for their own goals, or whether a simpler, month-to-month, medication-only provider would be a better financial fit.

Compounded Semaglutide vs Compounded Tirzepatide: Pricing Breakdown

Both core GLP-1 medications are billed on a 3-month minimum commitment, a structure that differs from some competitors who bill monthly with no minimum term:

• Semaglutide: starting at $133/month, billed at $399 for the initial 3-month plan.
• Tirzepatide: starting at $166/month, billed at $499 for the initial 3-month plan (Brello’s own homepage lists a discount from a $749 reference price to $499 for this plan).

According to Brello’s own start-wellness page, plans automatically renew at the applicable recurring rate roughly every ten to eleven weeks after the initial 3-month term, until the member cancels. Brello states members can cancel anytime, but the specific refund eligibility depends heavily on timing, which is covered in detail below. As with any subscription-based compounded medication plan, prospective members should confirm the exact renewal cadence and total cost at checkout rather than relying solely on the advertised “starting at” monthly figure.

Cancellation and Refund Policy: The Details That Actually Matter

Brello’s refund policy is more specific, and more restrictive, than some competitors in this space, and it’s worth walking through precisely because the timing windows are narrow:

• If a member cancels before a provider-led health review is completed and no prescription has been written, Brello states the member will receive a full refund.
• If the health review is completed and a prescription has been written, Brello may refund the total amount paid minus a $50 professional services fee, but only if the member sends written cancellation notice to Brello’s support email within 24 hours of the completed provider review.
• Once medication has been dispatched, refunds are not issued, consistent with standard pharmacy regulations around dispensed compounded medications.
• If a member has concerns about their medication or suspects a dispensing error after delivery, Brello directs members to contact the dispensing pharmacy directly, using the contact information printed on the prescription label, within 48 hours of receiving the medication.
• Once a shipping carrier confirms delivery, Brello considers the order fulfilled and will not reship or replace it, even if the member reports non-receipt; in that scenario, the member would need to pay for a new order and file any lost-or-stolen-package claim directly with the courier.

The practical takeaway here is that the refund window is genuinely narrow, 24 hours from the completed provider review, not 24 hours from time of purchase or plan selection. Members who anticipate wanting to cancel after review should watch their email closely once their intake is submitted rather than assuming they have an extended window to decide.

Community and Add-On Features

Beyond the medication itself, Brello bundles in several features as part of its plan pricing rather than as separate paid add-ons:

• Brello Rise — a library of virtual fitness and nutrition classes spanning yoga, boxing, dance, pilates, and mobility work, streamed through the app.
• Private Facebook Community — a members-only group Brello describes as a space for daily accountability and peer encouragement.
• Brello App — used for tracking progress, messaging providers, and managing plan details and renewals.

These features are marketed as differentiators against lower-cost, no-frills compounded GLP-1 competitors, and they’re a reasonable factor to weigh for members who want more structure and community support built into a weight-management program rather than medication alone.

What Compounding Means, and Why It’s Repeated So Often

Drug compounding is a legal, regulated practice in the United States in which a licensed pharmacy combines or modifies ingredients to prepare a medication tailored to an individual patient’s prescription. Brello sources its compounded medications through a USA-based 503A pharmacy, the standard regulatory category for patient-specific compounded prescriptions. Compounding is often used when a commercially manufactured, FDA-approved medication isn’t accessible, isn’t tolerated, or isn’t available due to supply constraints, which has been a significant factor behind GLP-1 shortages in recent years.

What compounding does not mean is FDA approval. Brello states this directly and repeatedly across its site: compounded drug products are not reviewed or verified by the FDA for safety, effectiveness, or quality. A licensed healthcare provider is required to evaluate whether a compounded medication is necessary or appropriate for each individual patient, which is precisely the role Brello’s independent prescriber network is meant to serve.

General Safety Considerations With GLP-1 Therapy

GLP-1 and GLP-1/GIP medications, whether compounded or FDA-approved, carry a well-documented set of common side effects reported in clinical literature on the drug class generally, most frequently gastrointestinal: nausea, diarrhea, constipation, and appetite suppression, particularly when starting treatment or increasing dose. These effects are often most noticeable early in treatment. Any severe or persistent symptoms should be reported to a prescribing provider rather than managed independently.

Because this is a prescription medication requiring individualized clinical judgment, nothing in this article should be treated as medical advice or a substitute for a provider’s evaluation. Patients with a personal or family history of certain thyroid conditions, pancreatitis, or specific gastrointestinal disorders are generally considered poor candidates for this medication class, which is exactly the kind of history a thorough intake questionnaire and provider review are designed to catch. Full, honest disclosure during intake matters more than any other single step in this process.

Reputation and Member Feedback

Brello links to Trustpilot reviews directly from its own homepage and states it serves roughly 80,000 active members. Feedback shared on Brello’s own site and linked review platforms commonly describes positive experiences with shipping presentation (cold packaging arriving intact), responsiveness of customer support, and satisfaction with pricing relative to other compounded GLP-1 providers members say they previously used. Some members also describe reported weight changes over specific timeframes in their own reviews.

It’s important to treat those individual, self-reported results as anecdotal rather than as a clinical outcome measure. Weight-loss results vary significantly by individual based on dose, adherence, diet, activity level, and underlying health factors, and no single member’s reported outcome should be read as a typical or guaranteed result for anyone considering the program.

State Availability

Brello operates a live, interactive map on its homepage showing which states currently have no shipping delays versus which are unavailable, and the company states it is actively expanding into additional states over time. Given the pharmacy transition mentioned earlier in this overview, prospective members should check that live map at the time they’re considering enrollment rather than assuming nationwide availability.

Frequently Asked Questions

Is Brello Health built specifically for women?
Yes, based on the company’s own homepage messaging, Brello frames its program specifically around helping women pursue weight management and longevity goals, and its community features are built around that audience.

Is the medication cost included in the plan price?
According to Brello’s own FAQ, yes, if a provider approves the prescription, the cost of medication is included in the selected plan price rather than billed separately.

What’s the minimum commitment?
All plans require a 3-month minimum commitment before a member can cancel without forfeiting the ability to receive a full refund for an unreviewed order.

Can I get a refund after my prescription is written?
Only within a 24-hour window from when the provider-led review was completed, and only minus a $50 professional services fee. Refunds are not available after medication has been dispatched.

What happens if my package is marked delivered but I never received it?
Per Brello’s refund policy, the company considers the order fulfilled once the carrier confirms delivery and will not reship. Members in that situation would need to purchase a new order and pursue a claim directly with the shipping carrier.

Does Brello include anything besides medication?
Yes. Plans include access to Brello Rise fitness and nutrition classes, a private Facebook community, and the Brello mobile app for tracking progress and messaging providers.

Who This Program May Fit

Based on Brello’s own positioning and published plan structure, this program tends to appeal to women specifically seeking a fully virtual, community-supported path to compounded GLP-1 or longevity medication, who are comfortable with a 3-month minimum commitment and want fitness and nutrition resources bundled into the price rather than purchased separately. It may be a less obvious fit for anyone who wants a strictly month-to-month plan with no minimum term, or for anyone already stable on an FDA-approved brand-name GLP-1 medication through insurance, since Brello’s pricing is structured for cash-pay members rather than as an insurance substitute.

Anyone considering Brello, or any comparable compounded GLP-1 or longevity telehealth provider, should disclose their complete medical history during intake, read the refund policy’s timing windows carefully before enrolling, and discuss alternatives, including FDA-approved medication options, with their provider if those represent a better clinical fit.

The Bottom Line

Brello Health sits in a specific niche within the broader compounded GLP-1 telehealth market: women-focused positioning, a 3-month minimum subscription structure, and bundled community and fitness features rather than medication sold on its own. Its pricing, semaglutide starting at $133/month and tirzepatide starting at $166/month, is competitive within that category, and its intake-to-delivery process follows the same general structure used across most of its competitors. Where Brello differs most concretely from some other providers is its refund policy’s narrow 24-hour cancellation window after provider review, and its current pharmacy-transition notice affecting shipping timelines, both of which are worth reading in full before enrolling rather than relying on general marketing claims.

As with any prescription treatment, the right decision depends on an individual’s full medical history and goals, not on price, bundled perks, or community features alone. Anyone considering Brello should go into the intake process with complete and honest information and treat the resulting provider review as a genuine clinical checkpoint.

View current Brello Health program details

Important: Any information provided in this article is for informational purposes only and should not be construed as medical advice; it is not a substitute for professional medical consultation, diagnosis, or treatment. All patients must consult with a healthcare provider prior to the prescription or dispensing of any medication, which will be done only pursuant to a valid prescription. Compounded drug products are not FDA-approved, and the FDA does not evaluate their safety, effectiveness, or quality. Patients are encouraged to discuss the risks, benefits, and appropriateness of any medications, including compounded products, with their healthcare provider before use.